{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus Palyam : Questions médicales les plus fréquentes",
"headline": "Virus Palyam : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus Palyam : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus Palyam"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Orbivirus",
"url": "https://questionsmedicales.fr/mesh/D018163",
"about": {
"@type": "MedicalCondition",
"name": "Orbivirus",
"code": {
"@type": "MedicalCode",
"code": "D018163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.223.719.550"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus Palyam",
"alternateName": "Palyam Virus",
"code": {
"@type": "MedicalCode",
"code": "D030081",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duncan R Smith",
"url": "https://questionsmedicales.fr/author/Duncan%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand. duncan_r_smith@hotmail.com."
}
},
{
"@type": "Person",
"name": "Atitaya Hitakarun",
"url": "https://questionsmedicales.fr/author/Atitaya%20Hitakarun",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Nitwara Wikan",
"url": "https://questionsmedicales.fr/author/Nitwara%20Wikan",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Sittiruk Roytrakul",
"url": "https://questionsmedicales.fr/author/Sittiruk%20Roytrakul",
"affiliation": {
"@type": "Organization",
"name": "National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, 12120, Thailand."
}
},
{
"@type": "Person",
"name": "Ronaldo Mohana-Borges",
"url": "https://questionsmedicales.fr/author/Ronaldo%20Mohana-Borges",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Structural Biotechnology and Bioengineering, Biophysics Institute Carlos Chagas Filho, Lab C0-36ss, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. mohana@biof.ufrj.br."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The work of Chinese chronic conditions: adaptation and validation of the Distribution of Co-Care Activities Scale.",
"datePublished": "2023-04-17",
"url": "https://questionsmedicales.fr/article/37139370",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2023.1091573"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Study on the Interoperability Technology of Digital Identification Based on WACI Protocol with Multiparty Distributed Signature.",
"datePublished": "2023-04-17",
"url": "https://questionsmedicales.fr/article/37112402",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23084061"
}
},
{
"@type": "ScholarlyArticle",
"name": "Organophosphate esters (OPEs) in the marine environment: Spatial distribution and profiles in French coastal bivalves.",
"datePublished": "2023-04-15",
"url": "https://questionsmedicales.fr/article/37062393",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chemosphere.2023.138702"
}
},
{
"@type": "ScholarlyArticle",
"name": "Does large volume of distribution of lidocaine masks its systemic uptake from bladder?",
"datePublished": "2023-04-15",
"url": "https://questionsmedicales.fr/article/37168943",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson's disease.",
"datePublished": "2023-04-13",
"url": "https://questionsmedicales.fr/article/37061026",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neulet.2023.137249"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN double brin",
"item": "https://questionsmedicales.fr/mesh/D000086122"
},
{
"@type": "ListItem",
"position": 5,
"name": "Reoviridae",
"item": "https://questionsmedicales.fr/mesh/D012087"
},
{
"@type": "ListItem",
"position": 6,
"name": "Orbivirus",
"item": "https://questionsmedicales.fr/mesh/D018163"
},
{
"@type": "ListItem",
"position": 7,
"name": "Virus Palyam",
"item": "https://questionsmedicales.fr/mesh/D030081"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus Palyam - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus Palyam",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus Palyam",
"description": "Comment diagnostiquer une infection par le virus Palyam ?\nQuels tests sont utilisés pour le virus Palyam ?\nLes symptômes aident-ils au diagnostic ?\nLe virus Palyam est-il identifiable par culture ?\nY a-t-il des marqueurs spécifiques pour le virus Palyam ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Normal+Distribution&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus Palyam",
"description": "Quels sont les symptômes courants du virus Palyam ?\nLes symptômes varient selon les individus ?\nLe virus Palyam cause-t-il des complications graves ?\nLes symptômes apparaissent-ils rapidement ?\nY a-t-il des symptômes spécifiques aux enfants ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Normal+Distribution&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus Palyam",
"description": "Comment prévenir l'infection par le virus Palyam ?\nLes vaccins existent-ils pour le virus Palyam ?\nLes mesures d'hygiène aident-elles à prévenir l'infection ?\nLes moustiquaires sont-elles efficaces contre le virus Palyam ?\nLes voyages dans certaines zones augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Normal+Distribution&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus Palyam",
"description": "Quel est le traitement principal pour le virus Palyam ?\nLes antibiotiques sont-ils efficaces contre le virus Palyam ?\nDes antiviraux sont-ils disponibles pour ce virus ?\nComment gérer les symptômes du virus Palyam ?\nLe repos est-il recommandé lors d'une infection ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Normal+Distribution&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus Palyam",
"description": "Quelles sont les complications possibles du virus Palyam ?\nLes complications sont-elles fréquentes ?\nComment les complications sont-elles traitées ?\nLes complications affectent-elles la récupération ?\nY a-t-il des facteurs de risque pour les complications ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Normal+Distribution&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus Palyam",
"description": "Quels sont les principaux facteurs de risque pour le virus Palyam ?\nLes personnes âgées sont-elles plus à risque ?\nLes voyageurs sont-ils à risque d'infection ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nY a-t-il des occupations à risque pour le virus Palyam ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Normal+Distribution&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le virus Palyam ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et la détection de l'ARN viral par PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le virus Palyam ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et la PCR sont couramment utilisés pour identifier le virus."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques peuvent orienter le diagnostic, mais ne suffisent pas seuls."
}
},
{
"@type": "Question",
"name": "Le virus Palyam est-il identifiable par culture ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture du virus est difficile et rarement utilisée pour le diagnostic clinique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour le virus Palyam ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticorps spécifiques peuvent être détectés, mais ils ne sont pas exclusifs au virus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du virus Palyam ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs musculaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier d'une personne à l'autre."
}
},
{
"@type": "Question",
"name": "Le virus Palyam cause-t-il des complications graves ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques peuvent survenir, bien que rares."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître rapidement, généralement dans les 3 à 7 jours après infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes similaires, mais souvent moins sévères."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus Palyam ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'évitement des piqûres d'insectes et l'utilisation de répulsifs."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour le virus Palyam ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin commercialisé contre le virus Palyam."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène aident-elles à prévenir l'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures d'hygiène appropriées peuvent réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles efficaces contre le virus Palyam ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation de moustiquaires peut aider à prévenir les piqûres d'insectes."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines zones augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques augmente le risque d'infection par le virus."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour le virus Palyam ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre le virus Palyam ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales comme le Palyam."
}
},
{
"@type": "Question",
"name": "Des antiviraux sont-ils disponibles pour ce virus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antiviraux spécifiques pour traiter le virus Palyam."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes du virus Palyam ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des symptômes inclut des analgésiques et des antipyrétiques pour la fièvre."
}
},
{
"@type": "Question",
"name": "Le repos est-il recommandé lors d'une infection ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos est conseillé pour aider le corps à combattre l'infection."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du virus Palyam ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des troubles neurologiques et des syndromes hémorragiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications graves sont rares, mais peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement des complications est symptomatique et peut nécessiter des soins intensifs."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la récupération ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent prolonger le temps de récupération et affecter la santé globale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs de risque pour les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées ou âgées peuvent avoir un risque accru de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour le virus Palyam ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des zones endémiques et un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus susceptibles de développer des complications."
}
},
{
"@type": "Question",
"name": "Les voyageurs sont-ils à risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs vers des régions où le virus est endémique courent un risque accru."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles ont un risque accru de développer des formes graves de l'infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des occupations à risque pour le virus Palyam ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs en milieu rural ou en contact avec des animaux peuvent être à risque."
}
}
]
}
]
}
The Distribution of Co-Care Activities Scale was adapted into Chinese for the purposes of this study, and then the psychometric characteristics of the Chinese version of the DoCCA scale were confirmed...
A total of 434 patients with chronic diseases were recruited from three Chinese cities. A cross-cultural adaptation procedure was used to translate the Distribution of Co-Care Activities Scale into Ch...
The Chinese DoCCA scale includes five domains: demands, unnecessary tasks, role clarity, needs support, and goal orientation. The S-CVI was 0.964. Exploratory factor analysis yielded a five-factor str...
The Chinese version of the Distribution of Co-Care Activities Scale had high levels of validity and reliability for chronic conditions. The scale can assess how patients with chronic diseases feel abo...
In digital identity authentication, credentials are typically stored in a digital wallet and authenticated through a single key-based signature and public key verification. However, ensuring compatibi...
Organophosphate esters (OPEs), chemicals widely used in industrial production, electronics and domestic products, have become ubiquitous environmental contaminants. In this study, the levels and spati...
To assess whether therapeutic and toxic effects of intravesical lidocaine are determined by coincident serum levels....
Published clinical trials and case studies on instilled lidocaine 1-2% that reported serum lidocaine levels were analyzed using model independent pharmacokinetic equations to compute the absorbed dose...
Rapid absorption of intravesical lidocaine is evinced by the serum levels of 0.16±0.3 mg/L at 5 min in bladder cancer patients coinciding with the rapid onset of pain relief (<5 min) and blood pressur...
Whether rapid absorption of instilled lidocaine is complicated by an equally rapid and extensive dilution in body weight dependent Vd can be resolved by early blood sampling (<30 min) for: evidence-ba...
The quantitative susceptibility mapping (QSM) technique was used to analyze the distribution pattern of iron deposition in the basal ganglia region of patients with motor subtypes of Parkinson's disea...
The study included 76 patients with PD and 37 healthy controls (HC). Patients with PD were divided into two groups: postural instability/gait disorder (PIGD)(n = 48), and tremor dominance (TD)(n = 28)...
(1) Compared with the HC, the bilateral SN in the PD-PIGD and TD group showed greater susceptibility values. The susceptibility values in the left CN, bilateral PUT were also greater in the PD-PIGD gr...
There were different iron deposition patterns in the basal ganglia between the PD-PIGD and TD groups. There also seems to be a difference in iron deposition in PD motor subtypes on different major mot...
Epirubicin is an anthracycline antineoplastic drug that is primarily used in combination therapies for the treatment of breast, gastric, lung and ovarian cancers and lymphomas. Epirubicin is administe...
In vitro experiments were conducted to determine the kinetics of epirubicin glucuronidation by human liver microsomes in the presence and absence of validated UGT2B7 inhibitors. A full physiologically...
Multivariable linear regression modelling demonstrated that variability in simulated systemic epirubicin exposure following intravenous injection was primarily driven by differences in hepatic and ren...
The present study describes the development and evaluation of a full-body PBPK model to assess systemic and individual organ exposure to epirubicin. Variability in epirubicin exposure was primarily dr...
Impaired iron transport (IIT) is a form of iron deficiency (ID) defined as transferrin saturation (TSAT) < 20% irrespective of serum ferritin levels. It is frequently observed in heart failure (HF) wh...
In this retrospective study we searched for a surrogate biomarker of IIT....
We tested the predictive power of red distribution width (RDW), mean corpuscular volume (MCV) and mean corpuscular haemoglobin concentration (MCHC) to detect IIT in 797 non-anaemic HF patients....
At ROC analysis, RDW provided the best AUC (0.6928). An RDW cut-off value of 14.2% identified patients with IIT, with positive and negative predictive values of 48 and 80%, respectively. Comparison be...
RDW may be seen as a reliable marker to exclude IIT in non-anaemic HF patients with eGFR ≥60 ml/min/1.73 m...
Fault detection for distributed parameter systems (DPSs) generally requires the complete model information to be known so far. However, for numerous industrial applications, it is common that accurate...
The aim of this study was to examine associations of gut microbiome diversity and composition with directly measured regional fat distribution, including central fat, in a large community-based cohort...
A cross-sectional investigation was conducted in the Baltimore Longitudinal Study of Aging (N = 815, 55.2% female, 65.9% White). The fecal microbiome was assessed using whole-genome shotgun metagenomi...
Trunk fat, leg fat, BMI, and waist circumference all significantly explained similar amounts of variance in microbiome structure. Differential abundance testing identified 11 bacterial species signifi...
Microbiome diversity and composition, in particular higher abundance of Ruminococcus gnavus, were associated with greater trunk fat, in addition to other measures of obesity. Longitudinal studies are ...
Sediment microbes are crucial for maintaining biogeochemical cycles in aquatic ecosystems, yet the influence of sediment geophysical structure on microbial communities remains unclear. In this study, ...